EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtOpen Access · CC BY 4.0

Cryoablation in Early-Stage Breast Cancer: A Systematic Review of Efficacy, Safety and Oncologic Outcomes

Sandra Maria Tsoti iD, Vasileios Kalles iD, Aristotelis Nikitaras, Ioannis Papapanagiotou iD, Nikolaos Michalopoulos

Cancers · 04.06.2026 · 18 (11) · 1842

DOI: 10.3390/cancers18111842 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 04.06.2026. Verfasst von Sandra Maria Tsoti und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, National and Kapodistrian University of Athens, 115 27 Athens, Greece. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cryoablation is a minimally invasive technique that is being investigated as an alternative to surgery for early-stage breast cancer. Its potential advantages include outpatient treatment under local anaesthesia, favourable cosmetic outcomes, and possible immunologic synergy. However, its oncologic efficacy and long-term effectiveness are yet to be determined.

Methods

We conducted a systematic review in accordance with PRISMA 2020 and the Cochrane Handbook, registered on PROSPERO (CRD420251137549). Databases searched were PubMed/MEDLINE, Scopus, and CENTRAL, from inception to August 2025. Eligible studies included women with unifocal, node-negative invasive ductal carcinoma ≤ 2 cm treated with percutaneous cryoablation. Outcomes of interest were residual disease, ipsilateral breast tumour recurrence, procedural and late complications, and cosmetic or patient-reported outcomes.

Results

From 1074 records, 15 unique studies (17 reports) were included, comprising cryoablation-only studies (n = 7), treat-and-resect studies (n = 6), and comparative studies versus surgery (n = 2). Studies containing overlapping pathology validation and comparative components were classified within a single category to avoid duplication. Across treat-and-resect cohorts, complete tumour necrosis was reported in 88–95% of cases, with residual invasive carcinoma (RIC) ranging from 5% to 12%. In cryoablation-only cohorts, IBTR rates ranged from 0% to 4.3%, with follow-up durations spanning 2 months to 8 years. The largest study (ICE3, n = 194) reported a 5-year recurrence rate of 4.3%. Procedural complications were infrequent and self-limiting, most commonly bruising, oedema, or superficial frostbite. No major adverse events were reported. Validated quality-of-life instruments reported high patient satisfaction, with favourable results in selected comparative domains. Most included studies were of moderate methodological quality.

Conclusions

Cryoablation appears technically feasible, safe, and cosmetically favourable in well-selected low-risk early-stage breast cancers. Oncologic outcomes are encouraging, with reported local recurrence rates in carefully selected low-risk populations being low, although direct comparison with breast-conserving surgery remains limited by the small number of comparative studies and substantial heterogeneity across the evidence base. Rigorous multicentre randomised trials with long-term follow-up and validated patient-reported outcomes are needed before cryoablation can be considered for routine clinical adoption.

Schlagwörter

Stichwörter der Autor:innen

breast cancercomplicationscosmetic outcomescryoablationearly-stage breast cancerlocal recurrenceresidual disease

Autor:innen und Institutionen

  • School of Medicine, National and Kapodistrian University of Athens, 115 27 Athens, Greece.
  • Mediterraneo Hospital, 166 75 Athens, Greece.
  • Euroclinic, 115 21 Athens, Greece.

ORCID-Profile: Sandra Maria Tsoti, Vasileios Kalles, Ioannis Papapanagiotou

Zitieren

APA

Tsoti, S. M., Kalles, V., Nikitaras, A., Papapanagiotou, I., & Michalopoulos, N. (2026). Cryoablation in Early-Stage Breast Cancer: A Systematic Review of Efficacy, Safety and Oncologic Outcomes. Cancers, 18(11), 1842. https://doi.org/10.3390/cancers18111842

Vancouver

Tsoti SM, Kalles V, Nikitaras A, Papapanagiotou I, Michalopoulos N. Cryoablation in Early-Stage Breast Cancer: A Systematic Review of Efficacy, Safety and Oncologic Outcomes. Cancers. 2026;18(11):1842. doi:10.3390/cancers18111842

BibTeX
@article{Tsoti2026,
  author = {Tsoti, Sandra Maria and Kalles, Vasileios and Nikitaras, Aristotelis and Papapanagiotou, Ioannis and Michalopoulos, Nikolaos},
  title = {Cryoablation in Early-Stage Breast Cancer: A Systematic Review of Efficacy, Safety and Oncologic Outcomes},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {11},
  pages = {1842},
  doi = {10.3390/cancers18111842}
}
Kostenlos starten →